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Background: Metabolic Syndrome (MS) is increasingly becoming a major worldwide clinical and public health
issue. Thus it is extremely important to study the history of MS and search for the most likely component
contributing to start the cascade of confusions of MS.
Methods: A longitudinal cohort was involved which included the data of 7510 individuals who had at least two
routine health check-ups in a six-year follow-up. Based on the data, a Markov model with each chain containing
seven states (no component state, four isolated states, 2-component state, and MS state) was built. Annual
transition probability was the mean of five probabilities for the transition between the given states between each
pair of consecutive years.
Results: The transition probabilities from the no component state to MS were higher in men than that in women
in four age groups. In the young people (men <60 years and women <50 years), the probabilities to the overweight
or obesity state and dyslipidemia state were the first two biggest probabilities in transition from no component to
the rest six states. However, in the elderly population, the probabilities to hypertension state and 2-component state
increased, even surpassed the above two states. The individuals initiating with 2-component states and the isolated
hyperglycemia state were more likely to develop MS than the others.
Conclusions: The Markov model was able to give a better description of the evolutionary history of MS, and to predict
the future course based on past evidence. The occurrence of the MS process mostly began with overweight or obesity
and dyslipidemia in young people. In the elderly population, many individuals initiating with hypertension or 2 components
besides the above two states. Individuals with the isolated hyperglycemia had greater chances to develop MS
than other isolated MS’ components.
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Metabolic syndrome (MS) is a clustering of metabolic risk
factors, including obesity, hypertension, dyslipidemia, and
insulin resistance [1,2]. MS can raise the risk of cardiovas-
cular disease (CVD) which is the leading killer in China
[3-5]. Evidence also suggests that MS is strongly correlated
with polycystic ovarian disease, nonalcoholic fatty liver
disease, and some cancers [6-8]. In fact, MS is increasingly* Correspondence: wshm@sdu.edu.cn
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Due to the great harm caused by MS, vast studies have
been done on it. Previous studies mainly focused on
searching for early MS’ biomarkers and risk factors, such
as white blood cell count (WBC), serum uric acid (UA),
gamma-glutamyl transpeptidase (GGT), alanine amino-
transferase (ALT), physical inactivity, alcohol intake, and
smoking habits [15-20]. Only a few studies focused on
the onset process of MS [21,22]. MS is defined as the ex-
istence of at least three of the four components at the
same time, thus there are 16 different states and 256
transitions between states. Therefore, stating the historytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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tributing to start the cascade of confusions are precondi-
tions for preventing its development. Haring et al. used
a network-based approach to show the prevalence and
progression of MS components and their changes [22],
but these predictions faced many barriers. The Markov
model which is frequently used to represent a random
process changing with time is an admitted method to
simulate the natural history of chronic diseases [23].
Lee-Ching Hwang et al. applied a Markov model ap-
proach to predict the development of MS [21]. However,
this study was only with young people and without inter-
mediate process conditions, it was limited. Therefore, we
conducted a Markov model with a six-year follow-up
health check-up including different genders and age
groups to describe the natural history of MS, determine
gender and age differences in the natural progression of
MS components and to predict the effect of different ini-
tial states on the development of MS.
Methods
Study samples
The participants for this study were collected during the
period from September 2006 to September 2011 in the
Health Management Center of Shengli Oilfield Central
Hospital in Dongying City, located in eastern China.
7510 subjects who had at least two health check-ups in
the six-year follow-up were involved in this study, the
maximum follow-up was 6 years and the mean follow-
up was 3.74 years. The Data for the first year enrolled in
the study following was considered “baseline” no matter
if that year was 2007, 2008, 2009 or 2010. Individual
who had a history of coronary heart diseases, type I dia-
betes, familial hyperlipidemia, and those who did not
provide complete information were excluded from the
analysis.
The occurrence of chronic diseases such as hyperten-
sion and hyperglycemia is closely related to age and gen-
der, so groups were classified by gender and age.
Individuals were divided into four age groups, the 18–40
year group, the 40–49 year group, the 50–59 year group
and the ≥60 year group, in two genders.
Measurements
All subjects underwent a doctor’s interview, anthropo-
metric and laboratory test. The doctor’s interview in-
cluded age, family history, and medical history. The
family history included certain genetic diseases such as
familial hyperlipidemia and the medical history con-
tained individuals’ medications such as taking antihyper-
tensive drugs. The anthropometric variables contained
weight, height and blood pressure. Weight and height
were measured with the subjects wearing light clothes
and no shoes. Body mass index (BMI) was obtained bydividing weight (kg) by squared height (m). Blood pres-
sure was measured twice in a comfortable quiet sitting
position with their right arm supported at the level of
the heart by a calibrated mercury sphygmomanometer
after at least 5 minutes rest. Laboratory tests contained
fasting blood-glucose (FPG), triglyceride (TG), and high
density lipoprotein cholesterol (HDL). FPG was tested
with the glucose oxidase method and TG and HDL were
measured by the enzymatic calorimetric test on blood
samples taken from the antecubital vein from the indi-
viduals who were under at least 12 hours fasting
conditions.
Definition of metabolic syndrome
The criteria given by Chinese Medical Association Dia-
betes Branch (CDS) was adopted to define MS in our study
[24]. Participants were diagnosed with MS if they had at
least three of the following four risk factors: (1) overweight
or obesity, BMI ≥25.0 kg/m2, (2) hypertension, systolic
blood pressure ≥140 mmHg, or diastolic blood pressure ≥
90 mmHg or previous diagnosed as hypertension, (3) dys-
lipidemia, fasting triglyceride (TG) ≥ 1.7 mmol/L(110 mg/
dl), or fasting high-density lipoprotein cholesterol (HDL) <
0.9 mmol/L(35 mg/dl), (4) hyperglycemia, fasting blood-
glucose (FPG) ≥ 6.1 mmol/L(110 mg/dl), or 2 h Post-meal
glucose (PG) ≥ 7.8 mmol/L(140 mg/dl), or previously diag-
nosed as hyperglycemia.
Markov model
7 states were included in each Markov chain: the no
component state, isolated overweight or obesity state,
isolated hypertension state, isolated dyslipidemia state,
isolated hyperglycemia state, 2-component state, and MS
state. Any two combinations of overweight or obesity,
hypertension, dyslipidemia or hyperglycemia formed a 2-
component state. These states were mutually exclusive
and collectively exhaustive. A cycle-based Markov model
was built and the graphical expression of the model was
shown in Figure 1. The development of MS is a complex
process and any state can develop into MS. Mutual tran-
sitions were allowed between the 7 states, so a reversible
multistate Markov model was adopted. In every Markov
cycle, the state could maintain or transition into any of
the other 6 states.
Individuals in every age and gender group were assigned
a probability of transitioning from one state to another or
maintaining their states in each Markov cycle and these
probabilities were calculated for annualized transitional
probabilities. First, individuals were designed to have no
component at the start of the model simulation in our
study and they could change their states every year. Other
Markov chains of different initial states, such as starting
with the isolated overweight or obesity state, isolated
hypertension state, isolated dyslipidemia state, isolated
Figure 1 A 7-state Markov model to describe the progression of metabolic components.
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conducted.
We used the annualized transitional probabilities cal-
culated from our six-year health check-up data to predict
the effect of different initial states on the development of
MS in the future 10 years in every age and gender group.
A series of assumptions was necessary to simplify the
process. (1) The future development depended only on an
individual’s current state and had no relationship with any
memory of prior states. (the Markov Chain assumption)
(2) Each baseline transition rate was a constant, independ-
ent of when baseline occurred during the follow-up
period.Statistical analysis
Means and percentages were calculated in the descrip-
tive analysis for both baseline and follow-up and analysis
of variance (ANOVA) and the Chi-square test were used
to find differences for the continuous and dichotomousvariables, respectively. Annual incidence rates were first
separately calculated between each pair of consecutive
years. Transition probabilities were the average of five
annual incidence rates in every age and gender group
which would increase the sample size and guarantee the
stability of the results. All these statistical analysis were
performed by SAS 9.1 and those two-sided p < 0.05 were
considered statistically significant. TreeAge pro 2011
software was used to construct the Markov models and
R2.14.2 was applied to draw figures.Ethic statements
This study was approved by the Ethics Committee of
School of Public Health, Shandong University and in-
formed oral consent was obtained from each participant.
The ethical review boards approved because many indi-
viduals involved in this study were workers from rural
areas, most of whom were illiterate. The consent pro-
cesses were documented in recorder pens.














Age (years) 41.02±10.26 41.86±10.21 43.57±10.16 45.38±10.16 47.67±10.86 46.53±7.72 <0.0001
Sex (male) 5118 (68.17%) 4299 (66.34%) 3592 (66.27%) 3041 (65.48%) 1879 (64.82%) 811 (73.33%) <0.0001
Overweight or
obesity
3088 (41.12%) 2642 (40.77%) 2346 (43.28%) 2057 (44.29%) 1198 (41.32%) 557 (50.36%) <0.0001
Hypertension 2237 (29.79%) 2505 (38.66%) 2335 (43.08%) 2251 (48.47%) 1568 (54.09%) 672 (60.76%) <0.0001
Dyslipidemia 2008 (26.74%) 1887 (29.12%) 1673 (30.87%) 1447 (31.16%) 954 (32.91%) 362 (32.73%) <0.0001
Hyperglycemia 614 (8.18%) 729 (11.26%) 770 (14.21%) 772 (16.62%) 615 (21.21%) 237 (21.43%) <0.0001
MS 893 (11.89%) 990 (15.28%) 985 (18.17%) 940 (20.24%) 661 (22.80%) 289 (26.13%) <0.0001
aValues for continuous characteristics were expressed as mean ± SD; values for categorical data were expressed as n (%).
bP for each row testing the null hypothesis that values for six years were equal.
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The general information of the baseline and each follow-
up year was shown in Table 1. During the six-year follow-
up, 7510 individuals were included in this study and the
total follow-up years were 28,059 person-years with a
mean 3.74 follow-up years per subject. MS prevalence in-
creased with greater time since baseline. Additional file 1:
Table S1 displayed the basic characteristics of the 7510
study individuals stratified by gender and age. All variables
were associated with age.
The Markov model and transition probabilities
Each annual transition probability was the mean of five
probabilities for the transition between the given states
between each pair of consecutive years. The annual tran-
sition probabilities for the Markov chain model which
displayed the natural history of MS divided by gender
and age were presented in Tables 2, 3, 4, 5 and 6 and
Additional file 1: Tables S2-S4. The transition probabil-
ities from no component state to MS were higher in
men than in women in four age groups and the same
trend could be seen from MS state to MS. However, the












Isolated hypertension 0 0 61.21
Isolated dyslipidemia 23.21 3.27 1.79
Isolated hyperglycemia 0 0 0
2 components 3.33 9.07 9.44
MS 0 0 3.78age. The probabilities for transition from isolated over-
weight state to MS for men were higher than women in
the first two age groups, but an opposite result was dem-
onstrated after age 50. The probabilities for transition
from any isolated state to the 2-component state were
always very high in the result that revealed the fact that
MS components always simultaneously occurred. In
men under 60 years old and women under 50 years old,
the probabilities to the overweight or obesity state and
dyslipidemia state were the first two biggest probabilities
in transition from no component to the rest six states.
However, in the elderly population, the probabilities to
hypertension state and 2-component state increased,
even surpassed the above two states.
Beginning with no component, any isolated component
state, or 2-component state
The prediction of the development of MS with the hypoth-
esis that individuals began with no component, any isolated
component or 2-component state was shown in Figures 2
and 3 and Additional file 2: Figures S1-S6 divided by gender
and age. Individuals beginning with any isolated component










7.68 0.58 4.55 1.09
3.35 0.51 24.07 5.28
0 0 26.67 12.12
42.86 0.30 22.32 6.25
0 48.57 31.43 20.00
2.50 0.83 54.17 20.65
0 0 23.92 72.30
Table 3 Annual transition probabilities (%) in Markov chain models for women in the 18–40 year group














No component 86.38 3.71 2.15 3.76 0.80 2.30 0.90
Isolated overweight or
obesity
37.81 44.27 0.50 4.98 0.50 9.45 2.49
Isolated hypertension 0 0 83.82 0 0 13.24 2.94
Isolated dyslipidemia 47.57 5.83 2.91 25.24 0.97 10.68 6.80
Isolated hyperglycemia 0 0 0 0 88.64 9.09 2.27
2 components 7.69 6.51 20.71 2.37 3.55 46.74 12.43
MS 0 0 25.00 0 0 42.31 32.69
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prediction of 10 years. Similarly, there was a greater chance
for the individuals starting with 2-component state and the
isolated hyperglycemia state to develop MS than the others.
Regardless of the beginning state, the possibility of develop-
ing MS after 10 years was extraordinarily similar.
Validation of the model
To validate the reality of our model, we compared the
estimated prevalence of MS in the model with the em-
piric data after 5 years in each gender and age group.
The outcomes were extremely similar.
Discussion
As well-known methods for simulating the history of
chronic diseases, Markov models were used in many stud-
ies. Feldman et al. used a longitudinal multistate Markov
model to study the causal relationship between allergic
sensitization and rhinovirus wheezing in 285 children at
high risk for allergic disease and asthma [25]. Similarly, a
Markov model analysis was used on a population-based
cohort to depict clinical course and costs of care for
Crohn's disease [26]. The patients are divided into differ-












Isolated hypertension 0 0 64.71
Isolated dyslipidemia 24.82 4.61 3.19
Isolated hyperglycemia 0 0 0
2 components 1.28 4.81 8.49
MS 0 0 2.60two states is given in the Markov model which applies to
medical areas [27]. Seven states were included in our study
and mutual conversion was allowed among them. The
Markov model was just able to achieve these transforma-
tions and to simulate the history of MS. Therefore, using a
routine health-check longitudinal cohort, our study mainly
focused on describing the natural history of MS, searching
for the most likely component contributing to start the
cascade confusions of MS, and predicting the effect of dif-
ferent initial states in 10 years by a reversible multi-state
Markov model.
It is still controversy about which state the process of
MS is most likely to begin with. A network-based study
on a five-year follow-up longitudinal cohort identified
central obesity and hypertension as the predominant MS
risk factor cluster [22]. Lee-Ching Hwang et al. claimed
that abdominal obesity or low HDL were the most likely
factors to initiate the progress of MS in women [21].
Similarly, a Baltimore Longitudinal Study on Ageing
demonstrated that abdominal obesity, low HDL choles-
terol, or high triglycerides were the predictors of inci-
dence of MS [28]. Limitations of these studies were that
their subjects were confined to certain gender or age










10.54 1.57 5.72 1.46
3.13 0.22 25.45 5.80
0 0 27.01 8.29
37.59 1.06 23.05 5.67
0 56.90 31.03 12.07
3.13 1.44 57.69 23.16
0 0.21 22.56 74.64
Table 5 Annual transition probabilities (%) in Markov chain models for women in the 40–49 year group














No component 82.05 5.45 3.70 4.61 0.84 2.65 0.70
Isolated overweight or
obesity
27.50 54.16 1.25 4.17 0.42 11.25 1.25
Isolated hypertension 0 0 86.80 0 0 11.46 1.74
Isolated dyslipidemia 38.25 3.48 3.48 42.61 0 9.57 2.61
Isolated hyperglycemia 0 0 0 0 73.81 19.05 7.14
2 components 3.16 3.95 21.34 3.16 3.95 49.02 15.42
MS 0 0 4.88 0 2.44 36.59 56.09
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and ≥60 years, in two genders. We confirmed that the
process of MS was most likely to begin with overweight
or obesity and dyslipidemia in the young population
(men <60 years and women <50 years). Also, we verified
that the most likely beginning states of MS included
hypertension state and 2-component state besides the
above two states in the elderly population (men ≥60 years
and women ≥50 years).
In the young people, obesity was defined as a main
contributor in the process of MS, because it was sus-
pected as a risk factor for hypertension, dyslipidemia
and hyperglycemia [29]. Dyslipidemia could cause hyper-
tension and hyperglycemia by mediating of free fatty
acids, but the causality between dyslipidemia and obesity
is still controversial. However, the beginning state chan-
ged with the growing age. The hormone level that affects
individuals’ metabolism changes with age especially dur-
ing menopause which results in the difference between
the young and elderly. Chedraui Pet al. demonstrated
that postmenopausal women with MS displayed higher
IL-6 (inflammation) and lower urokinase-type plasmino-
gen activator levels (endothelial dysfunction) which were












Isolated hypertension 0 0 66.40
Isolated dyslipidemia 22.97 1.35 1.35
Isolated hyperglycemia 0 0 0
2 components 0.53 2.79 7.85
MS 0 0 2.13occurrence of 2 components of MS at the same time [30].
Our research also found that men were more prone to de-
velop MS than women of the same age while increasing
age was an important factor inducing MS. The result was
accordant with Scuteri Aet al. who studied 34,821 subjects
from 12 cohorts in 10 European countries and one cohort
from the USA in the MARE (Metabolic syndrome and
Arteries RE search) Consortium [31].
We conducted a 10 years prediction with individuals be-
ginning with different states of MS according to the existing
transition probability. This is particularly important to pre-
vent the occurrence of MS. In the predictions, individuals
with the isolated hyperglycemia state had a greater chance
to develop MS than the other isolated states, and almost
reached the level of the individuals beginning with the 2-
component state. Insulin resistance is the defined patho-
genesis of diabetes and it commonly links the correlation to
the other MS components. Several studies confirmed that
four components of MS, obesity, hypertension, dyslipid-
emia, and hyperglycemia coexisted and influenced each
other [32,33]. There are some overlapping metabolic path-
ways in the pathogenesis of the four components of MS.
Diabetes is often accompanied by hypertension and they










7.92 3.96 7.59 1.98
4.79 0.53 20.21 6.91
0 0 29.25 4.35
36.49 2.70 29.73 5.41
0 53.57 30.36 16.07
1.60 1.33 60.24 25.66
0 0.15 21.46 76.26
Figure 2 The predictive development of MS according to various starting components in men in the 18–40 year group.
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kines, inflammatory pathway, and oxidative stress [34,35].
A study conducted in the USA pointed out that hyperten-
sion occurs in approximately 50% to 80% of patients with
type 2 diabetes and in 30% of patients with type 1 diabetes
[36]. A search in Hong Kong was in line with it, as only
42% of people with diabetes could maintain normal blood
pressure [37]. Hyperglycemia and dyslipidemia often occur
in the same individual but its mechanism still remains con-
troversial. Recently, it is suggested that cholesterol homeo-
stasis plays an important role for beta-cells to perform
adequate insulin secretion and low HDL cholesterol levels
are normally related with hyperglycemia and type 2 dia-
betes [38]. Although there is no theory supporting that
hyperglycemia could lead to obesity, central obesity had
been confirmed to be the most relevant predisposing factor
for insulin resistance [22,39]. It should be particularly
pointed out that glycemic control ought to attract more at-
tention and that the individuals once diagnosed withFigure 3 The predictive development of MS according to various starhyperglycemia should receive active defense to prevent the
emergence of the other components of MS.
We adopted CDS’ criteria to diagnose MS instead of
international standard criteria in our study. Compared to
Europeans and Americans, Chinese people have their own
body shape characteristics. Therefore, CDS developed
their own criteria which was also widely used in other
studies [17,18]. Previous study convinced that these two
MS diagnostic criteria were in good accordance [24]. Sim-
ultaneous, considering the fact that we lack of waist cir-
cumference measurement data, CDS’ criteria could make
our estimation more precise. Although CDS’ criteria we
adopted may result slight difference in diagnoses of MS
components compared to the international standard cri-
teria. This difference would hardly effect on the overall de-
veloping trend of MS.
There are several limitations in our study. First, the
person loss of follow-up was included in our study, and
it may affect the interpretation of the transitionalting components in women in the 18–40 year group.
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thest reduce the impact of it. Secondly, the natural his-
tory of MS development may be not completely natural
because of small part of interventions from the health
services. Thirdly, mortality was not included in our
model for the lack of the region specific information.
Considering the general situation of mortality in our
country, the influence is very small.Conclusions
The Markov model is able to give a good description of
the evolutionary history of MS and to predict the future
course based on the past evidence. Men are more prone
to develop MS than women of the same age. The occur-
rence of the MS process mostly began with overweight
or obesity and dyslipidemia in young people. In the eld-
erly population, many individuals initiating with hyper-
tension or 2 components besides the above two states.
Individuals with the isolated hyperglycemia had a greater
chance to develop MS than the other isolated MS’ com-
ponents. These results indicate the importance of moni-
toring the component of MS.Additional files
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stratified by gender and age. Table S2. Annual transition probabilities (%)
in Markov chain models for women in the 50–59 year group. Table S3.
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